US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Arcellx, Inc.

News headline image
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
From Arcellx, Inc.
Via Business Wire
Tickers ACLX GILD
News headline image
Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides Third Quarter 2025 Financial Results
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides First Quarter 2025 Financial Results and Business Highlights
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides Second Quarter 2024 Financial Results and Business Updates
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx Provides First Quarter 2024 Financial Results
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Participate in Two Upcoming Investor Conferences
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Arcellx, Inc.
Via Business Wire
Tickers ACLX
News headline image
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
From Arcellx, Inc.
Via Business Wire
Tickers ACLX